Assyro AI

FDA PDUFA dates in September 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in September 2026, sourced from FDA primary records.

Tracking 8 published FDA PDUFA decisions, including 6 NDAs and 2 BLAs.

FDA PDUFA dates in September 2026: 8 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
AdvicenneSibnayalNDAPENDING-provisional|advicenne|sibnayal|distalrenaltubulaupcoming
Telix PharmaceuticalsTLX101-Px (Pixclara)NDAPENDING-provisional|telixpharmaceuticals|tlx101pxpixclarupcoming
NuvalentzidesamtinibNDAPENDING-provisional|nuvalent|zidesamtinib|ros1positivenoupcoming
Ultragenyx PharmaceuticalUX111BLAPENDING-provisional|ultragenyxpharmaceutical|ux111|sanfiupcoming
MerckWINREVAIRBLAPENDING-provisional|merck|winrevair|pulmonaryarterialhypupcoming
Ionis PharmaceuticalszilganersenNDAPENDING-provisional|ionispharmaceuticals|zilganersen|aleupcoming
Praxis Precision MedicinesrelutrigineNDAPENDING-provisional|praxisprecisionmedicines|relutrigineupcoming
BiofronteraAmeluz-PDTNDAPENDING-provisional|biofrontera|ameluzpdt|superficialbasupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

September 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track September 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.